
Keywords: Chronic granulomatous disease; hyperinflammation; hematopoietic stem cell; dysfunctional hematopoiesis; competitive repopulation assay; engraftment defect; cell cycle; IL-1β; anakinra; gene therapy; BM; Bone marrow; BrdU; 5-Bromo-2â²-deoxyuridine; CFU;